You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Pediatrics Medical Group, Inc. reported adjusted EBITDA of $85 million in Q3 2026 and narrowed its full-year 2026 outlook to $290 to $300 million. Same-unit revenue remained positive, with equal contributions from volume and pricing.
Pediatrix reported third-quarter net revenue of $501.4 million, up 1.7%, but net income fell to $47.0 million and Adjusted EBITDA declined to $85.5 million; nine-month Adjusted EBITDA rose to $220.1 million as cash fell to $311.9 million.
Pediatrix Medical Group reported third-quarter 2026 net revenue of $501 million, net income of $47 million and Adjusted EBITDA of $85 million, and forecast full-year 2026 Adjusted EBITDA of $290 million to $300 million.
